MOBILion Systems is enabling advancements in disease diagnosis and treatment by commercializing instruments that improve multi-omics disease, drug, and biomarker discovery. Enhancing the study of the complement to genomics provides a better understanding of disease and drug target mechanisms and paves the way for earlier disease detection, more accurate diagnostics, improved treatment options for individual patients, and reduced healthcare costs.
MOBILion’s instruments provide unprecedented speed, sensitivity and resolution, allowing rapid detection of clinically relevant molecules such as proteins, peptides, metabolites, lipids, etc., to better predict, diagnose and treat disease. MOBILion’s instruments process population scale samples in days vs. years, and detect low abundance molecules never before seen with existing instrumentation, providing researchers and clinicians with increased confidence in clinical results.
Executive Leadership
All Members
HR & Accounts
Sales & Marketing
IT Support
Melissa Sherman, PhD
Chief Executive Officer
Melissa has a successful track record of building and advancing early stage businesses that are based
Craig Carra
Chief Financial Officer
Craig has over 20 years’ experience in the life sciences industry working in multiple executive level
Frederick Strathmann, PhD, MBA, DABCC (CC, TC)
Senior Vice President of Clinical & Applied Markets
Fred has over 10 years of experience in laboratory medicine, and has held various positions including
James Atwood, PHD
Senior Vice President of Biopharma & Discovery Omics
James brings over 15 years of experience leading businesses that develop and supply products and services
Team
All Members
HR & Accounts
Sales & Marketing
IT Support
Daniel DeBord, PhD
Vice President of R&D
Daniel will guide MOBILion’s SLIM prototype through to commercialization utilizing his extensive experience in the field
Gregory Webster
Vice President of Product Development
Greg manages the product development strategy and guides MOBILion through the development process. Greg has 10
Brett Peterson
Director of North American Sales
Brett has over 15 years of experience in the LC/MS industry. Originally a bioanalytical scientist in
Darren Stivale
Director of Manufacturing & Supply Chain
Ed Cywinski
Controller
Paul Sakach
Service Manager
Paul’s focus throughout his four decade career has been exclusively in analytical instrumentation. He has worked
Sarah Folmar
Senior Manager, Human Resources
Sarah is a proven human resources leader with over twenty years of experience. Throughout her tenure,
Advisory Board
All Members
HR & Accounts
Sales & Marketing
IT Support
David Speicher, PhD
David received his Ph.D. in Biochemistry from Pennsylvania State University, followed by postdoctoral training at Yale Medical School. He is currently the Caspar Wistar Professor
Ravinder Singh, PhD
Ravinder is the director of the Mayo Clinic Endocrine Laboratory. He has a focused area of investigation that has broad applicability to the field. Dr.
Gustavo Salem
Mr. Salem is Co-Founder and Managing Partner at Eureka Life Science LLC, a management consulting firm focused on value creation for life science and diagnostics
John McLean, PhD
John A. McLean is Stevenson Professor of Chemistry, Chair of the Department of Chemistry, Chair of the Faculty Senate, and Director of the Center for
Gordon Logan, PhD
With over 30 years of experience, Gordon Logan is a recognized senior leader in the analytical instrumentation and informatics industry. Gordon's consultancy focus is delivering
Kaveh Kahen, PhD
Dr. Kaveh Kahen is currently the CEO of the Advion group. For nearly three decades, Advion has been focused on delivering customer-focused life science solutions
Sally Curley
Sally is Founder and CEO of Curley Global IR, LLC, an Investor Relations, Environmental-Social-Governance Survey and Corporate Governance strategic advisory firm. With more than 30
Kevin Bateman, PhD
Kevin is a Scientific Associate Vice President at Merck Research Laboratories in the Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM). Currently he is the
Tim Germann
Tim is the Chief Commercial Officer at Carterra. He’s spent the last 31 years commercializing technology in the life sciences and healthcare. For the last
Board of Directors
All Members
HR & Accounts
Sales & Marketing
IT Support
Jenn Buechel
Jenn brings over 20 years of experience in launching products in a wide variety of industries, with a particular focus on bringing novel healthcare technologies from R&D to market. Jenn
Tad Weems
Tad is Managing Director of Agilent’s Early Stage Partnership team that manages the partnership/investment relationships of over 30 early stage life science tools companies. He has been in the life
Todd Sone
Todd is a Partner at aMoon and has over 20 years of healthcare investment experience. Todd serves on the boards of Ayala Pharmaceuticals (AYLA), Biolojic Design, Theranica, and Smart Medical
Jason Smith, PhD
Jason currently oversees the Life Sciences sector in North America for the IP Group. He has extensive experience developing and commercializing healthcare technology in large private and small start-up environments.
Melissa Sherman, PhD
Chief Executive Officer
Melissa has a successful track record of building and advancing early stage businesses that are based on high value, breakthrough science in the regulated medical products sector. Melissa will lead
Heiner Dreismann, PhD
Chairman
Heiner is a seasoned executive with more than 35 years of experience in the life sciences and health care industries and is regarded as a pioneer in the early adoption